Galia Oberkovitz

503 total citations
11 papers, 379 citations indexed

About

Galia Oberkovitz is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Galia Oberkovitz has authored 11 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Galia Oberkovitz's work include Cell death mechanisms and regulation (5 papers), Immunotherapy and Immune Responses (3 papers) and Chemokine receptors and signaling (3 papers). Galia Oberkovitz is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Immunotherapy and Immune Responses (3 papers) and Chemokine receptors and signaling (3 papers). Galia Oberkovitz collaborates with scholars based in Israel, United States and Georgia. Galia Oberkovitz's co-authors include Yehudit Zaltsman, Hagit Niv, Atan Gross, Limor Regev, Gal Haimovich, Iris Kamer, Yaniv Lerenthal, Rachel Sarig, Richard Marcellus and Ori Brenner and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Blood.

In The Last Decade

Galia Oberkovitz

11 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galia Oberkovitz Israel 6 300 90 60 57 55 11 379
Yoshiki Sumitomo Japan 7 352 1.2× 79 0.9× 62 1.0× 59 1.0× 55 1.0× 12 451
Todd D. Westergard United States 7 423 1.4× 87 1.0× 76 1.3× 35 0.6× 54 1.0× 9 478
Seemana Bhattacharya United States 11 402 1.3× 168 1.9× 72 1.2× 42 0.7× 47 0.9× 23 483
Markus Schick Germany 11 209 0.7× 107 1.2× 32 0.5× 41 0.7× 39 0.7× 24 320
Pravina Fernandez United States 4 514 1.7× 79 0.9× 103 1.7× 52 0.9× 43 0.8× 11 572
Elisa Panada Italy 3 249 0.8× 53 0.6× 35 0.6× 79 1.4× 64 1.2× 3 389
Le Xuan Truong Nguyen United States 12 319 1.1× 81 0.9× 101 1.7× 39 0.7× 82 1.5× 30 416
Adrianne N. Hanks United States 8 347 1.2× 136 1.5× 28 0.5× 134 2.4× 50 0.9× 9 472
Steven S. Foster United Kingdom 8 503 1.7× 132 1.5× 30 0.5× 14 0.2× 54 1.0× 8 554

Countries citing papers authored by Galia Oberkovitz

Since Specialization
Citations

This map shows the geographic impact of Galia Oberkovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galia Oberkovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galia Oberkovitz more than expected).

Fields of papers citing papers by Galia Oberkovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galia Oberkovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galia Oberkovitz. The network helps show where Galia Oberkovitz may publish in the future.

Co-authorship network of co-authors of Galia Oberkovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Galia Oberkovitz. A scholar is included among the top collaborators of Galia Oberkovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galia Oberkovitz. Galia Oberkovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Golan, Talia, Maya Gottfried, Alona Zer, et al.. (2022). Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer.. Journal of Clinical Oncology. 40(4_suppl). 110–110. 1 indexed citations
2.
Hidalgo, Manuel, Ron Epelbaum, Ravit Geva, et al.. (2018). Evaluation of pharmacodynamic (PD) biomarkers in patients with metastatic pancreatic cancer treated with BL-8040, a novel CXCR4 antagonist.. Journal of Clinical Oncology. 36(5_suppl). 88–88. 4 indexed citations
3.
Gaur, Pankaj, Vivek Verma, Seema Gupta, et al.. (2018). CXCR4 antagonist (BL-8040) to enhance antitumor effects by increasing tumor infiltration of antigen-specific effector T-cells.. Journal of Clinical Oncology. 36(5_suppl). 73–73. 7 indexed citations
4.
Abraham, Michal, Galia Oberkovitz, Baruch Bulvik, et al.. (2017). The CXCR4 Antagonist BL-8040 Induces a Robust Mobilization of CD34+CD38−CD45RA−CD90+ CD49f+ HSCs with Long-Term and Secondary Myeloid and Lymphoid Repopulating Activity. Blood. 130(Suppl_1). 660–660. 1 indexed citations
5.
Abraham, Michal, Inbal Mishalian, Shiri Klein, et al.. (2017). Effect of BL-8040, high-affinity CXCR4 antagonist, on T-cell infiltration, tumor growth, and synergy with immunomodulatory agents.. Journal of Clinical Oncology. 35(15_suppl). e14544–e14544. 2 indexed citations
6.
Borthakur, Gautam, Martin S. Tallman, Yishai Ofran, et al.. (2016). Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients. Clinical Lymphoma Myeloma & Leukemia. 16. S28–S28. 1 indexed citations
7.
Maryanovich, Maria, Galia Oberkovitz, Hagit Niv, et al.. (2012). The ATM–BID pathway regulates quiescence and survival of haematopoietic stem cells. Nature Cell Biology. 14(5). 535–541. 116 indexed citations
8.
Oberkovitz, Galia, et al.. (2009). PKCη confers protection against apoptosis by inhibiting the pro-apoptotic JNK activity in MCF-7 cells. Experimental Cell Research. 315(15). 2616–2623. 29 indexed citations
9.
Oberkovitz, Galia, Limor Regev, & Atan Gross. (2007). Nucleocytoplasmic shuttling of BID is involved in regulating its activities in the DNA-damage response. Cell Death and Differentiation. 14(9). 1628–1634. 13 indexed citations
10.
Abu‐Ghanem, Sara, Galia Oberkovitz, Daniel Benharroch, Jacob Gopas, & Etta Livneh. (2007). PKCη expression contributes to the resistance of hodgkin's lymphoma cell lines to apoptosis. Cancer Biology & Therapy. 6(9). 1371–1376. 27 indexed citations
11.
Kamer, Iris, Rachel Sarig, Yehudit Zaltsman, et al.. (2005). Proapoptotic BID Is an ATM Effector in the DNA-Damage Response. Cell. 122(4). 593–603. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiki Sumitomo Breakdown of academic impact, for papers by Todd D. Westergard Breakdown of academic impact, for papers by Seemana Bhattacharya Breakdown of academic impact, for papers by Markus Schick Breakdown of academic impact, for papers by Pravina Fernandez Breakdown of academic impact, for papers by Elisa Panada Breakdown of academic impact, for papers by Le Xuan Truong Nguyen Breakdown of academic impact, for papers by Adrianne N. Hanks Breakdown of academic impact, for papers by Steven S. Foster
Rankless by CCL
2026